Saving the vision of children with juvenile rheumatoid arthritis- associated uveitis

JAMA

Volumn 280, Issue 13, 1998, Pages 1133-1134

  Nguyen, Quan Dong ^a   Foster, C Stephen ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOSPORIN; METHOTREXATE; NAPROXEN; PREDNISONE; TRIAMCINOLONE ACETONIDE;

ALGORITHM; CLINICAL FEATURE; DISEASE ASSOCIATION; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SHORT SURVEY; TREATMENT PLANNING; UVEITIS; VISUAL IMPAIRMENT;

EID: 3543125855     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.13.1133     Document Type: Short Survey

References (20)

1. Smith R, Nozik R. Uveitis in childhood. In: Smith R, Nozik R, eds. Uveitis: A Clinical Approach to Diagnosis and Management. Baltimore, Md: Williams & Wilkins; 1989:113-114.
2. Kanski JJ. Uveitis in juvenile chronic arthritis. Eye. 1988;2:641-645.
3. O'Brien J, Albert D, Foster CS. Juvenile rheumatoid arthritis. In: Albert D, Jakobiec FA, eds. Principles and Practice of Ophthalmology: Clinical Practice. Philadelphia, Pa: WB Saunders Co; 1994:2873-2887.
4. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987;94:1242-1248.
5. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104:236-244.
6. Candell Chalom E, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997;24:2031-2034.
7. Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology. 1993;100:809-817.
8. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-799.
9. Peterson LS, Mason T, Nelson AM, et al. Juvenile rheumatoid arthritis in Rochester, Minnesota, 1960-1993. Arthritis Rheum. 1996;39:1385-1390.
10. Chylack LT Jr, Bienfang DC, Bellows AR, Stillman JS. Ocular manifestations of juvenile rheumatoid arthritis. Am J Opthalmol. 1975;79:1026-1033.
11. American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology. Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 1993;92:295-296.
12. Olson NY, Lindsley CB, Godfrey WA. Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis. AJDC. 1988;142:1289-1292.
13. Makela AL. Naproxen in the treatment of juvenile rheumatoid arthritis. Scand J Rheumatol. 1977; 6:193-205.
14. Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin 1992;32:241-252.
15. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. N Engl J Med. 1992;326:1043-1049.
16. Ramadan A, Nussenblatt R. Cytotoxic agents in ocular inflammation. Ophthalmol Clin North Am. 1997;10:377-387.
17. Morgan SL, Baggott JE, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 1990;33:9-18.
18. Sibilia J, Liote F, Mariette X. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. Rev Rheum Engl Ed. 1998; 65:267-273.
19. Lane L, Tamesis R, Rodriguez A, et al. Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease. Ophthalmology. 1995;102:1530-1535.
20. Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology. 1996;103:365-370.